0001144204-14-010654.txt : 20140219
0001144204-14-010654.hdr.sgml : 20140219
20140219173336
ACCESSION NUMBER: 0001144204-14-010654
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140214
FILED AS OF DATE: 20140219
DATE AS OF CHANGE: 20140219
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DERMA SCIENCES, INC.
CENTRAL INDEX KEY: 0000892160
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 232328753
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 6095144744
MAIL ADDRESS:
STREET 1: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DERMA SCIENCES INC
DATE OF NAME CHANGE: 19940513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: QUILTY EDWARD J
CENTRAL INDEX KEY: 0001045507
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13070
FILM NUMBER: 14626934
MAIL ADDRESS:
STREET 1: DERMA SCIENCES, INC.
STREET 2: 214 CARNEGIE CENTER, SUITE 300
CITY: PRINCETON
STATE: NJ
ZIP: 08540
4
1
v369186_4.xml
OWNERSHIP DOCUMENT
X0306
4
2014-02-14
0
0000892160
DERMA SCIENCES, INC.
DSCI
0001045507
QUILTY EDWARD J
DERMA SCIENCES, INC.
214 CARNEGIE CENTER, SUITE 300
PRINCETON
NJ
08540
1
1
0
0
President & CEO
Common Stock
2014-02-14
4
A
0
7900
0
A
159793
D
Common Stock
2014-02-14
4
M
0
6250
12.40
A
166043
D
Common Stock
2014-02-14
4
F
0
5871
13.20
D
160172
D
Stock Option (right to buy)
11.97
2014-02-14
4
A
0
26300
0
A
2014-02-14
2023-02-13
Common Stock
26300
26300
D
Stock Option (right to buy)
13.39
2014-02-14
4
A
0
36000
0
A
2014-02-14
2024-02-14
Common Stock
36000
36000
D
Stock Option (right to buy)
12.40
2014-02-14
4
M
0
6250
0
D
2004-02-24
2014-02-24
Common Stock
6250
0
D
The shares of common stock reported herein represent restricted stock units issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on February 13, 2013, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2013, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2013 were met, resulting in the vesting of 7,900 restricted stock units.
Shares delivered in connection with the cashless exercise of 6,250 options, previously granted pursuant to the issuer's stock option plan, at an exercise price of $12.40, as reported herein.
The options reported herein were issued under the issuer's equity incentive plan in consideration of the reporting person's services to the issuer granted on February 13, 2013, subject to the issuer's satisfaction of certain performance criteria for the fiscal year ending December 31, 2013, and further subject to continued employment through the vesting date. Certain of the performance criteria for 2013 were met, resulting in the vesting of 26,300 options.
The options, granted pursuant to the issuer's equity incentive plan, vested as to 25% on the grant date and will vest as to an additional 25% on February 14 of 2015, 2016 and 2017.
The options, granted pursuant to the issuer's stock option plan, vested as to 25% on the grant date, and vested as to an additional 25% on February 24 of 2005, 2006 and 2007.
The options were originally granted in consideration of the reporting person's services to the issuer and without payment of cash.
/s/ Edward J. Quilty
2014-02-19